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Adrenal cortex steroids are essential for body homeostasis, and
adrenal insufficiency is a life-threatening condition. Adrenal endo-
crine activity is maintained through recruitment of subcapsular
progenitor cells that follow a unidirectional differentiation path from
zona glomerulosa to zona fasciculata (zF). Here, we show that this
unidirectionality is ensured by the histone methyltransferase EZH2.
Indeed, we demonstrate that EZH2 maintains adrenal steroidogenic
cell differentiation by preventing expression of GATA4 and WT1 that
cause abnormal dedifferentiation to a progenitor-like state in Ezh2
KO adrenals. EZH2 further ensures normal cortical differentiation by
programming cells for optimal response to adrenocorticotrophic hor-
mone (ACTH)/PKA signaling. This is achieved by repression of phospho-
diesterases PDE1B, 3A, and 7A and of PRKAR1B. Consequently, EZH2
ablation results in blunted zF differentiation and primary glucocorticoid
insufficiency. These data demonstrate an all-encompassing role for
EZH2 in programming steroidogenic cells for optimal response to
differentiation signals and in maintaining their differentiated state.
adrenal | differentiation | progenitors | PKA signaling | EZH2
The adrenal gland is composed of two tissues: The inner me-dulla is derived from the neural crest and is an integral part
of the sympathetic nervous system, and the cortex is a key ste-
roidogenic tissue which synthesizes mineralocorticoids, gluco-
corticoids, and adrenal androgens in primates. This endocrine
activity is essential for life, and adrenal insufficiency is lethal in
the absence of hormonal substitution (1). This activity relies on
functional zonation. In rodents, this is characterized by differ-
entiation of zona glomerulosa (zG) in the upper third of the
cortex, which produces aldosterone, and zona fasciculata (zF) in
the remainder, which synthesizes glucocorticoids (2). We have
recently shown that this functional zonation is established and
maintained despite continuous cell renewal by antagonistic in-
teractions between WNT/β-catenin signaling in zG and PKA
signaling in zF (3). Cortical cell renewal is a slow but continuous
process which relies on a number of progenitor cells localized at
the periphery of the gland (4). In homeostatic conditions, SF1-
positive, sonic hedgehog (SHH)-positive cells within the zG
niche are recruited for differentiation as CYP11B2-positive zG
cells in response to WNT signaling activation by RSPO3/WNT4
(5–7). These cells move farther within the cortex and subsequently
differentiate as zF cells upon PKA activation and WNT pathway
repression (3). Although lineage tracing studies have demonstrated
the unidirectionality of the renewal process in the adult (5, 6),
namely SF1-positive cells never give rise to undifferentiated capsular
progenitors, the situation is quite different in the embryo. Indeed,
differentiated fetal steroidogenic adrenal cells, characterized by
expression of the fetal enhancer of SF1 (8), were shown to con-
tribute to the pool of capsular GLI1-positive, SF1-negative pro-
genitors that were found during embryonic development but also in
the adult (9). Altogether, these data raise the question of the mo-
lecular mechanisms that ensure that progenitors acquire and
maintain an adrenal steroidogenic differentiation program once
they engage in centripetal cortex renewal.
Epigenetic factors play essential roles in programming and
maintaining cell-fate decisions during embryonic development
and in adult tissue homeostasis (10). Recently, we have shown
that the histone methyltransferase EZH2 is the most deregulated
epigenetic factor in adrenal cortex carcinoma in which it is as-
sociated with cancer progression (11). Here, we investigated the
role of EZH2 in adrenocortical development and homeostasis by
targeted inactivation of EZH2 in adrenal cortex steroidogenic
cells using SF1:Cre, which is active as soon as the adrenal pri-
mordium emerges from the adreno-gonadal primordium (AGP)
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(12), and a floxed allele of Ezh2 (13). Our data show that
EZH2 ablation is associated with deficient zona fasciculata dif-
ferentiation, resulting in primary glucocorticoid insufficiency. This
is caused by decreased PKA signaling pathway activity, in response
to release of EZH2/PRC2–mediated repression of phosphodies-
terases PDE1B, 3A, and 7B. We further show that Ezh2 ablation
results in disruption of the unidirectional renewal and differenti-
ation process. This is characterized by expansion of a pool of SF1-
negative progenitor-like cells in the outer cortex that originate
from dedifferentiation of SF1-positive steroidogenic cells. Alto-
gether, these data demonstrate an all-encompassing role of EZH2 n
programming steroidogenic cells for optimal response to differen-
tiation signals and in preventing their dedifferentiation to a
progenitor-like state.
Results
Ezh2 Ablation Results in Up-Regulation of PRC2 Target Genes. To
evaluate the role of EZH2 in adrenal cortex homeostasis, we
mated mice with a floxed Ezh2 allele (Ezh2 Fl/Fl) (13) with mice
bearing a Cre recombinase under the control of SF1 regulatory
regions (SF1:Cre) (12), which allows recombination as early as
E10.5 in steroidogenic cells of the developing adrenal cortex
(referred to as Ezh2 KO mice hereafter). We also included the
mTmG reporter system to trace cells that have undergone re-
combination (14). Efficient deletion of Ezh2 in the adrenal cortex
was assessed by immunohistochemistry (IHC) at E14.5. In wild-
type adrenals (Sf1:Cre,mTmG,Ezh2+/+), EZH2 was strongly
expressed in the nuclei of all steroidogenic cells, identified by
membrane expression of GFP from the mTmG locus, following
SF1:Cre–mediated recombination (Fig. 1 A, a). In contrast,
EZH2 was almost undetectable in GFP-positive steroidogenic
cells in knockout adrenals (Sf1:Cre,mTmG,Ezh2 Fl/Fl), indicating
efficient deletion of the floxed allele (Fig. 1 A, b). This was further
confirmed by a marked reduction in H3K27me3 accumulation in
the nuclei of GFP-positive cells in E18.5 and adult knockout ad-
renals (Fig. 1 A, d and SI Appendix, Fig. S1A), compared with wild
type (Fig. 1 A, c and SI Appendix, Fig. S1A). Although EZH2 is
the catalytic subunit of the PRC2 repressive complex, recent data
suggest that it can also function as a transcription activator through
interaction with transcription factors such as the androgen receptor
(AR) (15). To gain insight into the activity of EZH2 in the adrenal
cortex, we conducted microarray analysis of gene expression in
three wild-type and four knockout adrenals from 2-mo-old female
mice. Interestingly, out of the 309 genes that were significantly
deregulated, the majority (193) was up-regulated, suggesting that
deletion of Ezh2 was associated with a release of repression (Fig.
1B). To evaluate this hypothesis, we performed gene set enrichment
analysis (GSEA) using curated PRC2 target gene lists (Fig. 1C, SI
Appendix, Fig. S1B, and Dataset S1). These showed significant
enrichment of PRC2 target gene sets, further supporting the idea
that EZH2 activity in the adrenal cortex was associated with PRC2-
mediated gene repression.
Ezh2 Ablation Causes Primary Glucocorticoid Insufficiency and
Aberrant Zonal Differentiation. We then evaluated the impact of
EZH2-PRC2 inactivation on adult female adrenal physiology.
Hematoxylin and eosin staining of adrenal sections showed marked
reduction in adrenal size, which was associated with significant
disruption of architecture, characterized by misplacement of adre-
nal medulla (Fig. 2A and SI Appendix, Fig. S2A) and thinning and
disorganization of the columnar structure of zona fasciculata (Fig.
2A). Although the medulla was displaced, there was no major im-
pact of cortical Ezh2 ablation on chromaffin cell function (SI Ap-
pendix, Fig. S2 B and C). In contrast, Ezh2 ablation was associated
with the absence of the fetal cortex-derived X zone in nulliparous
females (SI Appendix, Fig. S2 D and E). Hypoplasia of the gland was
further confirmed by a significant decrease in adrenal weight (Fig.
2B), which was associated with cortical cell hypertrophy (Fig. 2C),
suggesting that adrenal endocrine activity was altered. Consistent with
this idea, plasma corticosterone concentration was significantly de-
creased at 9 AM (Fig. 2D) and at different time points during the day
(SI Appendix, Fig. S2F). This was associated with increased plasma
adrenocorticotrophic hormone (ACTH) (Fig. 2E), indicating that
Ezh2 KO mice presented primary glucocorticoid insufficiency. In-
terestingly, plasma aldosterone concentration was unaltered (Fig. 2F),
Fig. 1. Ezh2 ablation in the adrenal cortex results in up-regulation of PRC2 target genes. (A) Immunohistochemical detection of EZH2 (a and b; E14.5) and
H3K27me3 (c and d; E18.5) together with GFP expressed from the mTmG locus following Sf1:Cre-mediated recombination, in both wild-type (a and c; Sf1:Cre,
mTmG,Ezh2+/+) and knockout adrenals (b and d; Sf1:Cre,mTmG,Ezh2 Fl/Fl). Ad, adrenal. (Scale bars, 50 μm.) (B) Heatmap representing the median centered
expression of the significantly deregulated genes [false discovery rate (FDR) < 0.1] in 2-mo-old female EZH2 knockout adrenals (n = 4) compared with wild-
type littermates (n = 3). Expression data were extracted from microarray analyses using Affymetrix chips. FC, fold change. (C) Gene set enrichment analysis of
microarray gene expression data using curated EZH2/PRC2 target gene lists. NES, normalized enrichment score.
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even though renin activity was decreased (Fig. 2G). This suggested
that EZH2 inactivation mostly had an impact on zF differentiation.
To gain insight into zonal differentiation status, we performed GSEA
of our microarray data using zona fasciculata- and zona glomerulosa-
specific gene sets extracted from previously published microarray
analyses of microdissected rat adrenal zones (16) (Dataset S1).
Consistent with primary glucocorticoid insufficiency, there was a
significant negative enrichment of zF-specific genes in Ezh2 KO
adrenals compared with wild type (Fig. 2H, Left). However, there
was a concomitant positive enrichment of zG-specific genes (Fig.
2H, Right), suggesting that zG differentiation may be favored by
Ezh2 ablation. To gain insight into the tissue phenotype, we an-
alyzed expression of AKR1B7, a marker of zF, by IHC. As expected,
AKR1B7 was expressed throughout zF and excluded from zG in
wild-type adrenals (Fig. 2 I, a). In contrast, expression of
AKR1B7 was markedly reduced and restricted to the innermost
cortex in Ezh2 KO adrenals, indicating deficient zF differentia-
tion (Fig. 2 I, b). This was further confirmed by decreased
Cyp11b1 mRNA accumulation (Fig. 2J). Evaluation of zG dif-
ferentiation using DAB2 staining showed significant expansion in
Ezh2 KO adrenals compared with wild type (Fig. 2 I, c). This was
confirmed, albeit more subtly, by expansion of the CYP11B2 ex-
pression domain (Fig. 2 I, f vs. e). Interestingly, coimmunohistochem-
istry for both DAB2 and AKR1B7 showed further alterations of
adrenal zonal differentiation, which resulted in the presence of
DAB2-positive cells (zG) deep within zF (Fig. 2 I, h vs. g, asterisks)
and in the aberrant differentiation of cells with both zF and zG
identity (Fig. 2 I, h vs. g, arrowheads). Surprisingly, even though zG
was expanded in Ezh2 KO adrenals, aldosterone production was
normal (Fig. 2F). This was probably the result of decreased renin
activity (Fig. 2G) acting as a feedback mechanism. This hypothesis
was supported by decreased mRNA accumulation of At1a and
At1b, encoding the two receptors for Angiotensin II (Fig. 2J).
Altogether, these data indicated that Ezh2 ablation resulted in
profound alterations of adrenal cortex zonation characterized by
inhibition of zF differentiation and glucocorticoid production at
the benefit of zG expansion, despite normal aldosterone output.
EZH2 Programs Adrenal Steroidogenic Cell Response to PKA Signaling.
We have previously shown that adrenal cortex zonation results
from a subtle equilibrium between WNT pathway activation in zG
and PKA activation in zF (3). We thus evaluated the activity of
both pathways in response to EZH2 inactivation. GSEA of WNT
pathway-associated targets and regulators showed positive albeit
nonsignificant enrichment in Ezh2 KO adrenals compared with
wild type (SI Appendix, Fig. S3A). This suggested that WNT
pathway activity was only mildly altered in response to Ezh2 ab-
lation. Consistent with this, there were no canonical WNT target
Fig. 2. EZH2 ablation is associated with primary glucocorticoid insufficiency and aberrant zonal differentiation. (A) Hematoxylin and eosin staining of 2-mo-
old female wild-type and Ezh2 KO adrenals, showing a marked difference in size, cortical hypoplasi, and dysplasia and misplaced adrenal medulla. Ca, capsule;
Co, cortex; M, medulla. (Scale bars, 200 μm.) (B and C) Adrenal weight (B) and relative cortical cell surface (C) in 2-mo-old female wild-type and Ezh2 KO
adrenals. (D–G) Plasma corticosterone (D), ACTH (E), aldosterone (F), and renin (G) activity in 2-mo-old female wild-type and Ezh2 KO mice. RFU, relative
fluorescence units. (H) GSEA of microarray gene expression data, using curated zona fasciculata- and zona glomerulosa-specific gene lists. (I) Immunohis-
tochemical detection of AKR1B7 (zF; a and b), DAB2 (zG; c and d), and CYP11B2 (zG) and coimmunostaining for AKR1B7 and DAB2 in 2-mo-old female wild-
type and Ezh2 KO adrenals. White arrowheads indicate cells with costaining for DAB2 and AKR1B7; asterisks indicate misplaced DAB2-positive cells. (Scale
bars, 50 μm.) (J) RT-qPCR analysis of accumulation of mRNAs encoding steroidogenic enzymes (Cyp11b1, Cyp21, Hsd3b1, Cyp11b2), zone-specific markers
(Akr1b7, Dab2), and Angiotensin II receptors (At1a, At1b) in 2-mo-old female wild-type and Ezh2 KO adrenals. Bars represent the mean expression in seven
animals per group ± SEM. ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001.
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genes within the genes significantly up-regulated in KO adrenal
microarray data (SI Appendix, Fig. S3B), and RT-qPCR analysis of
Lef1, Axin2, and Apccd1 mRNA accumulation only showed mod-
erate up-regulation of Apcdd1 (SI Appendix, Fig. S3C). This was
further supported by the mild expansion of the LEF1 expression
domain in the cortex of Ezh2 KO adrenals, compared with wild
type (SI Appendix, Fig. S3D). Altogether, these data suggested that
Ezh2 ablation had a mild impact on the activity of WNT pathway in
the adrenal cortex. We thus evaluated the effect of Ezh2 ablation
on PKA signaling pathway activity. GSEA of steroidogenesis and
cholesterol synthesis gene sets, which represent two pathways that
are positively regulated by PKA (17), showed significant negative
Fig. 3. EZH2 programs the capacity of adrenal steroidogenic cells to respond to PKA signaling. (A) GSEA of microarray gene expression data using curated
steroidogenesis and cholesterol synthesis (mevalonate pathway) gene lists. (B) Immunohistochemical detection of Pan-PKA substrates (a and b) and phos-
phorylated CREB protein together with GFP (cells of the steroidogenic lineage; c and d) in 2-mo-old female wild-type and Ezh2 KO adrenals. (C) Western blot
analysis of P-CREB accumulation in seven 2-mo-old female wild-type and Ezh2 KO adrenals. Graph shows quantification of P-CREB over CREB signal. (D) ELISA
quantification of basal and cAMP-induced PKA activity in adrenal extracts from four female wild-type and four female Ezh2 KO 2-mo-old adrenals. (E)
Heatmap representing the median centered expression of significantly deregulated PKA pathway regulators (FDR < 0.1) in 2-mo-old female Ezh2 KO
compared with wild-type adrenals. (F) RT-qPCR analysis of accumulation of mRNAs encoding inhibitors of the PKA signaling pathway in 2-mo-old female wild-
type and Ezh2 KO adrenals. Bars represent the mean expression in seven animals per group ± SEM. (G) Chromatin immunoprecipitation of H3K27me3 and
EZH2 on the regulatory regions of PKA pathway inhibitors in 2-mo-old female wild-type and Ezh2 KO adrenals. Enrichments were normalized to input for
each experiment and are expressed as relative enrichment of the same marks on the regulatory regions of the housekeeping gene GAPDH. (H) Immuno-
histochemical detection of EZH2 in E15.5, E18.5, 1-mo, and 6-mo wild-type adrenals. (I) Coimmunostaining for DAB2 (zG) and AKR1b7 (zF) in E18.5 wild-type
and Ezh2 KO adrenals. White arrowheads indicate cell staining for both DAB2 and AKR1B7; the asterisk indicates a misplaced DAB2-positive cell. (J and K) RT-qPCR
analysis of accumulation of mRNAs encoding zonal differentiation markers (J) and PKA signaling inhibitors (K) in 2-mo-old female wild-type and Ezh2 KO adrenals.
Bars represent the mean expression in seven animals per group ± SEM. (L) Coimmunostaining for EZH2, DAB2 (zG), and AKR1B7 (zF) in a 2-mo-old female wild-type
adrenal. Arrowheads indicate EZH2-positive cells. (M) Coimmunostaining for EZH2 and Ki67 in a 2-mo-old female wild-type adrenal. Arrowheads indicate cell
staining for both EZH2 and Ki67. Asterisks indicate cells only staining for EZH2. ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001. (Scale bars, 50 μm.)
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enrichment in KO adrenals (Fig. 3A). This suggested that PKA
activity may be down-regulated by Ezh2 ablation. Consistent with
this idea, there was a clear decrease in global PKA-mediated sub-
strate phosphorylation in Ezh2 KO adrenals compared with wild
type (Fig. 3 B, b vs. a). This was further supported by a marked
decrease in CREB phosphorylation in GFP-positive recombined zF
cells in KO adrenals (Fig. 3 B, d vs. c) and a significant reduction in
global P-CREB accumulation measured by Western blot on whole-
adrenal extracts (Fig. 3C). To confirm alteration of PKA signaling
pathway activity, we measured PKA activity on whole-adrenal
extracts. Interestingly, this showed a significant decrease in basal
activity in KO adrenals, although it was still as sensitive to cAMP
induction as in wild type (Fig. 3D). This suggested that the defect in
PKA pathway activity was situated upstream of catalytic activity.
However, RT-qPCR analyses did not show any alteration in the
expression of Mc2r or of its cofactor Mrap that are essential to
mediate PKA response to ACTH (SI Appendix, Fig. S4A). To
further understand the molecular underpinnings of decreased PKA
activity, we evaluated expression of PKA regulators in our micro-
array data. This showed significant up-regulation of the negative
regulators Pde7b, Pde3a, Pde1b, and Prkar1b (Fig. 3E), which was
further confirmed by RT-qPCR analyses on an independent group
of animals (Fig. 3F). Altogether, these data suggested that EZH2
was required to mount an optimal response to PKA in the adrenal
cortex by inhibiting expression of negative PKA regulators, in par-
ticular phosphodiesterases. Consistent with this idea, analysis of
publicly available ChIP-sequencing data showed enrichment of
EZH2/H3K27me3 on a number of phosphodiesterase regulatory
regions in 14 different cell types (SI Appendix, Fig. S4B). To test this
possibility in the adrenal, we evaluated enrichment for H3K27me3
and EZH2 on the promoters of Prkar1b, Pde1b, Pde3a, and Pde7b in
wild-type and Ezh2 KO adrenals. Consistent with a role of PRC2-
mediated gene repression, we observed a significant enrichment
(from three- to eightfold) for H3K27me3 on the promoters of all
four negative PKA regulators compared with the housekeeping
gene Gapdh in wild-type adrenals (Fig. 3G). This was associated
with moderate recruitment of EZH2 (Fig. 3G). Interestingly, en-
richment for H3K27me3 was significantly decreased for all four
genes in KO adrenals, whereas EZH2 recruitment was significantly
reduced on Pde1b and Pde3a regulatory regions (Fig. 3G). Alto-
gether, these data showed that EZH2/PRC2 promoted PKA
pathway activity by repressing expression of negative regulators of
PKA signaling through deposition of the H3K27me3 mark on their
promoters. However, the low level of enrichment for EZH2 on
promoters in the presence of high levels of H3K27 trimethylation
raised the question of EZH2 expression in the adult adrenal. Ki-
netic analysis showed high levels of expression throughout the ad-
renal gland at E15.5 (Fig. 3H, a), which was progressively restricted
to the cortical periphery by E18.5 (Fig. 3 H, b). This pattern was
further restricted at 1 mo, and very few cells at the periphery of the
cortex expressed EZH2 by 6 mo (Fig. 3 H, c and d). Even though
EZH2 expression markedly decreased over time, H3K27me3 levels
appeared relatively constant up to 6 mo (SI Appendix, Fig. S4C).
This suggested that PKA responsiveness of steroidogenic cells may
be established by EZH2 activity during embryonic development. To
evaluate this, we analyzed the adrenal differentiation phenotype at
E18.5, when differentiation of zonae glomerulosa and fasciculata
becomes evident. Indeed, in wild-type adrenals, we observed a clear
separation of the expression domains of DAB2 (zG) and AKR1B7
(zF) (Fig. 3 I, a). In contrast, Ezh2 KO adrenals showed inter-
mingling of the two domains and a number of cells with double–zG/
zF identity that were not present in the wild type (Fig. 3 I, b vs. a).
This was also associated with decreased expression of Cyp11b1 and
Akr1b7 in RT-qPCR (Fig. 3J) and significant up-regulation of
Pde1b (Fig. 3K). Altogether, these data strongly suggest that
EZH2 programs adrenal cortex cells for optimal response to
PKA signaling during embryonic development. However, al-
though adrenal cortex cell renewal is a relatively slow process
[12 wk in female mice (5)], this raises the question of H3K27me3
maintenance during cell divisions associated with this process.
Interestingly, analysis of EZH2 expression together with DAB2
and AKR1B7 showed that the few cells that expressed EZH2 in
the adult adrenal were localized within zG, at the boundary be-
tween zG and zF, or within outer zF (Fig. 3L). This localization
suggested that EZH2 may be reexpressed in cortical cells when
they enter the centripetal renewal process. This idea was further
confirmed by colocalization of EZH2 with Ki67 staining in the
outer cortex (Fig. 3M). Altogether, our data show that EZH2 is
essential to program PKA responsiveness in the developing ad-
renal cortex and in newly recruited adrenocortical cells during
adult cortex renewal.
Ezh2 Ablation Results in Accumulation of Progenitor-Like Cells. Re-
newal of the adrenal cortex is highly coordinated with zonal cell
differentiation to allow maintenance of adrenal homeostasis.
Given the central role of EZH2 in controlling zF differentiation
through the PKA signaling pathway, we evaluated a potential
role in controlling progenitor homeostasis. GSEA of microarray
data showed a significant positive enrichment for genes associ-
ated with adrenal progenitor regulation in Ezh2 KO compared
with wild-type adrenals (Fig. 4A). Consistent with this, H&E
staining showed massive expansion of fibroblastic-like cells,
characteristic of the capsular and subcapsular adrenal compart-
ment where progenitors reside in the wild-type adrenal (Fig. 4 B,
b vs. a). Abnormal expansion of the progenitor compartment was
further suggested by a large increase in the number of NR2F2-
positive cells following Ezh2 ablation (Fig. 4 B, d vs. c). Although
homeostatic renewal of the cortex occurs mainly through re-
cruitment of SF1-positive, SHH-positive cells located in the vi-
cinity of zG (6), a number of SF1-negative cells expressing WT1,
GLI1, or GATA4 can be recruited to meet supraphysiological
demand or in models of adrenal insufficiency (6, 18–20). In-
terestingly, analysis of microarray data showed up-regulation of
Gata4, Wt1, and Gli1, suggesting that supraphysiological pro-
genitors may be accumulating in Ezh2 KO adrenals (Fig. 4C). To
evaluate this hypothesis, we analyzed expression of the different
progenitor populations by IHC, RNAscope in situ hybridization,
and RT-qPCR. As expected, Shh was detected within zG in wild-
type adrenals (Fig. 4 D, a). Although the expression domain was
somewhat disrupted by the presence of numerous fibroblastic
cells in Ezh2 KO adrenals, the number of Shh-positive cells did
not seem to be altered by Ezh2 ablation (Fig. 4 D, b vs. a). This
was further confirmed by normal levels of Shh transcript accu-
mulation in Ezh2 KO adrenals (Fig. 4E). In contrast, Gli1 ac-
cumulation, which marks progenitor cells that respond to Shh
signaling, was markedly increased by Ezh2 ablation and was
detected in most fibroblastic-like cells, whereas it was restricted
to the capsule in wild-type adrenals (Fig. 4 D, d vs. c). An almost
threefold increase in Gli1 accumulation was confirmed by RT-
qPCR (Fig. 4E). The normal accumulation of both Shh and
Ptch1 (a target of SHH) (Fig. 4E) strongly suggested SHH-
independent accumulation of GLI1-positive cells. IHC for WT1
showed very weak expression in the adrenal capsule, as previously
described in wild-type mice (18). In contrast, a large number of
the fibroblastic-like cells that accumulated in Ezh2 KO adrenals
expressed high levels of WT1 (Fig. 4 D, e and f), which was as-
sociated with a sevenfold increase in Wt1 transcript accumulation
(Fig. 4F). Forced induction of WT1 in the adrenal cortex has been
shown to result in increased expression of GATA4, through direct
WT1 binding on Gata4 regulatory regions (18). Consistent with
this idea, whereas GATA4 was virtually absent from wild-type
adrenals, it was strongly expressed in fibroblastic-like cells fol-
lowing Ezh2 ablation (Fig. 4 D, g and h). This was also associated
with an eightfold increase in Gata4 mRNA accumulation (Fig.
4F). However, although there were cells with both WT1 and
GATA4 staining, the expression domain of GATA4 was broader
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than the expression domain of WT1 (Fig. 4G). This suggested that
GATA4 induction may be somewhat independent of WT1 induction.
Deregulation of WT1 and GATA4 expression in the adrenal has
been shown to result in aberrant gonadal-like differentiation. Con-
sistent with this, RT-qPCR analyses showed up-regulation of Pdgfra,
Foxl2, and Lhr, characteristic of gonadal differentiation (Fig. 4H).
Altogether, these data showed that Ezh2 ablation resulted in the
accumulation of cells with characteristics of supraphysiological
fibroblastic-like progenitors and aberrant gonadal-like differentiation.
EZH2 Prevents Dedifferentiation of Steroidogenic Cells. We then
sought to determine the origin of this phenotype. GATA4 and
WT1 cells have been shown to accumulate in the adrenal cortex of
mice following castration (18, 19). Although Sf1:Cre is also active
in the gonad, Sf1:Cre,Ezh2 Fl/Flmice of both sexes were fertile (SI
Appendix, Fig. S5A) and showed no alteration of gonadal histology
(SI Appendix, Fig. S5 B and C) or plasma gonadotrophin con-
centrations (SI Appendix, Fig. S5 D and E). This strongly sug-
gested that accumulation of GATA4- and WT1-positive cells in
Ezh2 KO adrenals was independent of a gonadal phenotype. To
rule out a possible effect of increased ACTH signaling resulting
from defective zF differentiation on the accumulation of supra-
physiological progenitors, we evaluated their presence during em-
bryonic development, when adrenal homeostasis is independent of
the pituitary. Although RT-qPCR analyses did not reveal de-
regulation of either Gata4 or Wt1 transcript accumulation at E14.5
(Fig. 5B), IHC analyses showed abnormal accumulation of GATA4
(Fig. 5 A, b vs. a) but not WT1 (Fig. 5 A, d vs. c) within Ezh2 KO
adrenals at this stage. By E18.5, GATA4-positive cells were detected
throughout the cortex (Fig. 5 A, f vs. e), which was correlated with
up-regulation of Gata4 mRNA accumulation in RT-qPCR (Fig.
5B). A small number of WT1-positive cells also appeared at the
periphery of the gland (Fig. 5 A, h vs. g), even though Wt1 mRNA
accumulation was unaltered (Fig. 5B). Altogether, these data
showed that accumulation of GATA4- and WT1-positive cells was
not an indirect effect resulting from deregulation of gonadal– or
pituitary–adrenal axes. It also indicated that in contrast with pre-
viously published data (18), GATA4 accumulation was independent
of and preceded WT1 accumulation in Ezh2 KO adrenals. We then
wanted to identify the adrenal-autonomous mechanism responsible
for accumulation of GATA4- and WT1-positive cells in response to
Ezh2 ablation. We first evaluated the possibility that this may be the
Fig. 4. Ezh2 ablation is associated with accumulation of cells with characteristics of adrenal progenitors. (A) GSEA of microarray gene expression data using a
curated list of adrenal progenitor-associated genes. (B) Hematoxylin and eosin staining (a and b) and immunohistochemical detection of the capsular marker
NR2F2 (c and d) in 2-mo-old female wild-type and Ezh2 KO adrenals. (C) Heatmap representing the median centered expression of significantly deregulated
progenitor-associated genes (FDR < 0.1) in 2-mo-old female Ezh2 KO compared with wild-type adrenals. (D) RNAscope in situ hybridization showing ex-
pression of Shh (homeostatic progenitors; a and b) and Gli1 (supraphysiological progenitors; c and d) and immunohistochemistry for WT1 (e and f) and GATA4
(g and h) in 2-mo-old female wild-type and Ezh2 KO adrenals. (E and F) RT-qPCR analysis of accumulation of mRNAs encoding key actors in the Hedgehog
pathway (E) and markers of supraphysiological progenitors (F) in 2-mo-old female wild-type and Ezh2 KO adrenals. Bars represent the mean expression in
seven animals per group ± SEM. (G) Coimmunostaining of WT1 and GATA4 in a 2-mo-old female Ezh2 KO adrenal. (H) RT-qPCR analysis of accumulation of
mRNAs encoding markers of gonadal-like differentiation in 2-mo-old female wild-type and Ezh2 KO adrenals. Bars represent the mean expression in seven
animals per group ± SEM. ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001. (Scale bars, 50 μm.)
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result of increased proliferation of the few GATA4+/WT1+ pro-
genitor cells that reside in the capsule of wild-type adrenals. IHC
analyses showed that there was no overall increase in the number of
Ki67+ cortical cells following Ezh2 ablation, both in IHC and RT-
qPCR (Fig. 5 C and D). Furthermore, even though some GATA4+
cells displayed Ki67 expression, most of them were Ki67-negative
(Fig. 5E), strongly suggesting that accumulation of GATA4+ cells
was independent of proliferation. GATA4 and WT1 are normally
expressed in the AGP and are turned off once the adrenal pri-
mordium becomes fully differentiated (18). We thus reasoned that
abnormal expression of both factors in Ezh2 KO adrenals may rely
on a direct role of EZH2 in their expression. Consistent with this
idea, ChIP qPCR analyses showed enrichment of H3K27me3 and
EZH2 on the regulatory regions of both GATA4 and WT1 and a
significant decrease in enrichment in Ezh2 KO adrenals (Fig. 5F).
This indicated that EZH2/PRC2 was directly involved in repressing
Fig. 5. EZH2 prevents dedifferentiation of steroidogenic cells toward a progenitor-like phenotype. (A) Immunohistochemical analysis of GATA4 and
WT1 expression in E14.5 (a–d) and E18.5 (e–h) wild-type (a, c, e, and g) and Ezh2 KO (b, d, f, and h) embryos. Kid, kidney. (B) RT-qPCR analysis of accumulation
of mRNAs encodingWt1 and Gata4 in E14.5 and E18.5 wild-type and Ezh2 KO adrenals. Bars represent the mean expression in 14 (E14.5) and 6 (E18.5) animals
per group ± SEM. (C) Immunohistochemical analysis of Ki67 expression in 2-mo-old female wild-type and Ezh2 KO adrenals. (D) Number of cortical Ki67-
positive cells in Ezh2 KO relative to wild-type adrenals. Bars represent the mean expression in six (E14.5) animals per group ± SEM (Left). RT-qPCR analysis of
accumulation of mRNAs encoding Ki67 in 2-mo-old female wild-type and Ezh2 KO adrenals. Bars represent the mean expression in seven animals per group ±
SEM. (E) Coimmunostaining of GATA4 and Ki67 in 2-mo-old female wild-type and Ezh2 KO adrenals. (F) ChIP of H3K27me3 and EZH2 on the regulatory
regions of Gata4 andWt1 in 2-mo-old female wild-type and Ezh2 KO adrenals. Enrichments were normalized to input for each experiment and are expressed
as relative enrichment of the same marks on the regulatory regions of the housekeeping gene GAPDH. (G) Coimmunostaining of Ezh2 and GFP (cells of the
steroidogenic lineage) in 2-mo-old female wild-type (a) and Ezh2 KO (b) adrenals. White arrowheads show EZH2-positive capsular cells. (H) Coimmunostaining
of SF1 (actual steroidogenic cells) and GATA4 and GFP (cells of the steroidogenic lineage) in 2-mo-old female wild-type (a, bearing Sf1:Cre and the mTmG
reporter) and Ezh2 KO (b) adrenals. (H, Right) Different overlays of the region delineated by the dashed rectangle (Left). (I) Coimmunostaining of SF1 (actual
steroidogenic cells) and GATA4 and GFP (cells of the steroidogenic lineage) in a 12-mo-old wild-type female adrenal (bearing Sf1:Cre and the mTmG reporter).
(I, Right) Different overlays of the region delineated by the dashed rectangle (Left). ns, not significant; **P < 0.01, ***P < 0.001. [Scale bars, 50 μm (A, E, and
G–I) and 200 μm (C).]
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Gata4 and Wt1 expression in the adrenal cortex. However, whether
EZH2 exerted this activity in capsular or steroidogenic cells was
unclear. To gain insight into this, we evaluated EZH2 localization in
wild-type and KO adrenals by IHC. Interestingly, at all of the stages
that we examined, EZH2 expression was low (embryonic develop-
ment; SI Appendix, Fig. S6A) or absent (adult adrenal; Fig. 5G) in
GFP-negative capsular cells in wild-type adrenals, whereas it was
high in GFP-positive steroidogenic cells during embryonic devel-
opment and the perinatal period (Fig. 5G and SI Appendix, Fig.
S6A). Consistent with the restricted activity of Sf1:Cre, there was no
recombination of GFP or Ezh2 in the capsule either during em-
bryonic development or in the adult (SI Appendix, Fig. S6A and Fig.
5G). This strongly suggested that EZH2 was essential to prevent
expression of GATA4 and WT1 within steroidogenic rather than
capsular cells. To further identify the mechanism involved in the
accumulation of these aberrant cells, we analyzed coexpression of
GATA4, SF1, and GFP to identify cells of the steroidogenic lineage.
As expected, in wild-type adrenals, GATA4 expression was virtually
undetectable and all cells that were GFP-positive (recombined cells)
were also positive for endogenous SF1 expression (Fig. 5 H, a). In
contrast, there was a large number of fibroblastic-like GATA4-
positive cells in Ezh2 KO adrenals (Fig. 5 H, b). Interestingly,
most of these cells did not express any detectable level of endoge-
nous SF1 expression. However, the vast majority expressed GFP,
indicating that although they were SF1-negative, they derived from
the steroidogenic lineage (Fig. 5 H, b). Analysis of serial sections
stained for WT1, SF1, and GFP also showed that WT1-positive
cells, despite being SF1-negative, were largely derived from the
steroidogenic lineage (SI Appendix, Fig. S6B). Altogether, these data
strongly suggest that the large majority of GATA4- and WT1-
positive fibroblastic-like cells that accumulate in Ezh2 KO adre-
nals originate from dedifferentiation of engaged steroidogenic cells.
Interestingly, a number of reports have shown that fibroblastic-like
cells also accumulate at the periphery of aging mouse adrenals (19).
However, these cells were thought to originate from capsular pro-
liferation/recruitment. To evaluate this hypothesis, we also per-
formed triple-IHC analysis in 12-mo-old wild-type adrenals.
GATA4-positive fibroblastic-like cells were also present at the pe-
riphery of the cortex, even though all spindle-shaped cells did not
express GATA4 (Fig. 5I). Consistent with their counterparts in Ezh2
KO adrenals, most GATA4-positive cells were also GFP-positive
but SF1-negative (Fig. 5I). This indicated that dedifferentiation of
already-engaged steroidogenic cells was also present in wild-type
adrenals at a later time point, which was consistent with extinction
of EZH2 expression in most steroidogenic cells over time (Fig. 3H).
Effect on Sex on Ezh2 Ablation.We have recently shown that adrenal
cortex renewal and the role of PKA signaling in adrenal cortex
homeostasis are modulated by the sex of the individual (17). To
gain insight into a potential effect of sex on Ezh2 function in the
adrenal, we also evaluated the phenotype in male mice. Consistent
with our data in female mice, Ezh2 ablation in male mice was
associated with adrenal hypoplasia (SI Appendix, Fig. S7 A and B),
primary glucocorticoid insufficiency (SI Appendix, Fig. S7 C and
D), and reduced zona fasciculata differentiation (SI Appendix, Fig.
S7 E and F), with concomitant expansion of zona glomerulosa and
aberrant differentiation of cells with both identities (SI Appendix,
Fig. S7E). In agreement with a central role of aberrant PKA sig-
naling in establishment of this phenotype, there was also a marked
decrease in PKA substrates and CREB phosphorylation in male
adrenals (SI Appendix, Fig. S7G). However, in contrast with fe-
males, adrenal insufficiency in males was more profound with a
significant decrease in aldosterone concentration (SI Appendix,
Fig. S7H and I), associated with a significant reduction in Cyp11b2
expression (SI Appendix, Fig. S7F). Consistent with female
knockout adrenals, the number of progenitor-like cells was also
markedly increased in male Ezh2 KO adrenals (SI Appendix, Fig.
S8A), and this was associated with increased Gli1, Ptch1 (SI Ap-
pendix, Fig. S8 A and B), WT1, and GATA4 (SI Appendix, Fig. S8
C and D) expression and aberrant expression of gonadal-like dif-
ferentiation markers (SI Appendix, Fig. S8E). Lineage tracing also
demonstrated that a majority of GATA4-positive cells originated
from dedifferentiation of already-engaged steroidogenic cells (SI
Appendix, Fig. S8F). Altogether, these data showed that Ezh2 ab-
lation in males recapitulated most of the phenotypes observed in
females. However, in contrast with females, we did not observe a
major deregulation of phosphodiesterase-coding genes (SI Ap-
pendix, Fig. S8G) but rather a decrease in Mc2r and Mrap ex-
pression (SI Appendix, Fig. S8H), which may account for decreased
PKA signaling in male adrenals.
Discussion
The adrenal cortex is maintained by different pools of capsular
and subcapsular undifferentiated progenitor cells that engage in
and maintain steroidogenic differentiation throughout their cen-
tripetal migration within the gland (4). Although we and others
have identified the molecular signals involved in zonal differen-
tiation, the mechanisms involved in maintaining global steroido-
genic differentiation during adrenal cortex renewal and cell
migration have remained elusive (3, 7, 21, 22). Here, we show that
the histone methyltransferase EZH2, by allowing appropriate
levels of PKA signaling and by preventing dedifferentiation to a
progenitor-like state, plays a central role in ensuring that adrenal
cortex cells maintain their steroidogenic potential, irrespective of
their position in the gland and for the lifespan of the individual.
Adrenal cortex zonal differentiation is characterized by es-
tablishment of zona glomerulosa in the outer cortex, which
synthesizes aldosterone and zona fasciculata in the inner cortex,
which synthesizes corticosterone in rodents and cortisol in hu-
mans. Our data show that Ezh2 ablation is associated with a
strong reduction in zF differentiation, which results in primary
glucocorticoid insufficiency, characterized by decreased plasma
corticosterone concentration in the context of increased ACTH
secretion. Consistent with the idea that zF and zG differentiation
are in balance in the cortex (3), IHC analysis of DAB2 and
CYP11B2, two markers of zG differentiation, shows expansion of
glomerulosa in response to Ezh2 ablation. Zonal differentiation
is dependent on antagonistic interactions between WNT signal-
ing in the outer cortex and PKA signaling in the inner cortex (7,
11, 22). Interestingly, EZH2 has been shown to directly inhibit
WNT signaling in intestinal stem cells to prevent their differ-
entiation (23) and in mesenchymal stem cells to allow their
adipogenic differentiation (24). Analysis of WNT pathway status
by microarrays and RT-qPCR in Ezh2 KO adrenals only showed
moderate alterations of some WNT regulators, which did not
translate into clear activation of the pathway. This suggests that
EZH2 does not play a central role in controlling WNT pathway
activity in the adrenal cortex. Consistent with this idea and in
contrast with the expanded zG in mice with constitutive activa-
tion of β-catenin (25, 26), expansion of zG in Ezh2 KO adrenals
was not associated with increased aldosterone secretion. This
suggests that these abnormally localized zG cells have retained
the capacity to respond to the renin-angiotensin system to
maintain aldosterone homeostasis. Indeed, our RT-qPCR anal-
yses showed decreased expression of the genes encoding angio-
tensin receptors AT1a and AT1b, associated with decreased
plasma renin activity in females and decreased Cyp11b2 expres-
sion in males. We thus reasoned that expansion of zG and
shrinking of zF may be the result of decreased PKA signaling
pathway activity in response to Ezh2 ablation. Indeed, our
combination of microarrays, RT-qPCR, IHC, and kinase activity
assays undoubtedly demonstrated that PKA activity was signifi-
cantly decreased in the adrenal cortex of Ezh2 KO mice. ChIP
analyses showed that this phenomenon was dependent on de-
repression of a set of phosphodiesterases (Pde1b, Pde3a, Pde7b)
and of one regulatory subunit of PKA (Prkar1b), which are all
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directly repressed by EZH2/PRC2 in normal female adrenals.
Our data further suggest that repression of these genes is pro-
grammed during embryonic development, when EZH2 is
expressed in all adrenal steroidogenic cells, and reestablished in
dividing cells in the adult gland through temporary reexpression
of EZH2. This shows an unexpected role of EZH2/PRC2 in
controlling activity of the PKA signalling pathway. Interestingly,
our analysis of publicly available ChIP-sequencing data shows
binding peaks of EZH2 and/or H3K27me3 on the regulatory
regions of a large number of phosphodiesterase genes and reg-
ulatory subunits of PKA in a set of 14 different cell types, in-
cluding cancer cell lines but also embryonic stem cells and
primary cultures of epithelial and fibroblastic cells. This strongly
suggests that EZH2/PRC2 may be regulating cAMP/PKA sig-
naling in tissues other than the adrenal.
Interestingly, although male adrenals recapitulate most of the
phenotypes found in females, including down-regulation of PKA
signaling pathway activity, we only observed mild up-regulation of
Pde3a in knockout male adrenals (SI Appendix, Fig. S8G). However,
in contrast with females, expression of the genes coding the ACTH
receptor MC2R and the accessory protein MRAP was significantly
down-regulated (SI Appendix, Fig. S8H). This suggests that some of
the activities of EZH2 in PKA signaling regulation differ between
males and females. We have previously shown that androgens can
indirectly inhibit PKA signaling through stimulation of the WNT
signaling pathway in the adrenal (17). Interestingly, EZH2 can in-
teract with the AR in castration-resistant prostate cancer cells,
resulting in transcription activation rather than repression (15).
Whether these interactions play a role in EZH2 activity in male and
female adrenals will require careful evaluation.
Decreased PKA activity in the adrenal, resulting from muta-
tions of the genes encoding ACTH receptor MC2R or its ac-
cessory protein MRAP, is associated with isolated familial
glucocorticoid deficiency (FGD), a potentially fatal condition if
left untreated (27, 28). These mutations only account for about
45% of FGD patients. Next-generation sequencing analyses have
identified other alterations such as mutations in NNT (29),
TXNRD2 (30), and GPX1 and PRDX3 (31), which disrupt cellular
oxidative stress balance, mutations in the MCM4 gene, which
encodes a component of a heterohexameric complex responsible
for normal DNA replication and chromosome stability (20), and
gain-of-function mutations of the cell-cycle inhibitor CDKN1C
(32). However, for about 25% of FGD cases there is still no ge-
netic diagnosis. Analyses are under way to identify alterations of
components of the PRC2 complex in these patients.
In homeostatic conditions, adrenal cortex renewal mostly occurs
through recruitment of SHH-positive progenitor cells within the zG
niche that initially differentiate as zG cells and undergo trans-
differentiation to zF identity (5). Capsular SF1-negative GLI1 and/
or WT1-positive cells give rise to a large number of steroidogenic
cells during embryonic development. They can also contribute, al-
beit at low frequency, to adrenal cortex replenishment in the adult
(6, 9, 18, 19, 33), and can be mobilized upon gonadectomy, giving
rise to adrenal neoplasia (34, 35), presenting characteristics of
adrenogonadal cells such as GATA4, LHR, and PDGFRα expres-
sion (19). Interestingly, aging mouse adrenals also present sub-
capsular accumulation of spindle-shaped cells (36, 37). Although
lineage tracing has shown that gonadectomy-induced lesions arise in
part from WT1/GLI1–positive cells, the origin of spindle-shaped
cells in the aging adrenal cortex is not as clear, even though
GLI1-positive cells may contribute to their appearance (19). Here,
we show that Ezh2 ablation results in the dramatic accumulation of
spindle-shaped GATA4, WT1, GLI1-positive, and SF1-negative
cells in the subcapsular region of 2-mo-old adrenals. Although we
cannot rule out a direct contribution of SF1-negative WT1/GLI1–
positive capsular cells to the subcapsular accumulation of these cells
in response to Ezh2 ablation, our experiments suggest a different
scenario: (i) EZH2 is expressed at very low levels in the capsule
and is not inactivated by Sf1:Cre in this compartment. (ii) Sub-
capsular GATA4-positive cells show no signs of increased pro-
liferation. (iii) Lineage tracing studies using Sf1:Cre and the
mTmG reporter system show that even though GATA4- andWT1-
positive spindle-shaped cells do not express SF1, they descend
from SF1-positive cells. (iv) ChIP shows that EZH2/PRC2 directly
represses expression of both GATA4 and WT1 in the adrenal
cortex. Altogether, these data strongly suggest that GATA4+/
WT1+ cells originate from dedifferentiation of SF1-positive ste-
roidogenic cells in response to Ezh2 ablation. Although de-
differentiation of steroidogenic cells was shown to contribute to the
GLI1-positive, SF1-negative capsular compartment during em-
bryonic development (9), such a phenomenon had not been shown
in the adult adrenal gland. Interestingly, our lineage tracing anal-
yses also suggest that this process is a strong contributor to the
accumulation of GATA4-positive, SF1-negative spindle-shaped
cells in wild-type aging adrenals. Our data showing progressive
extinction of EZH2 expression in steroidogenic cells over time
suggest that these cells may naturally dedifferentiate as a result of
loss of the H3K27me3 mark in dividing cortical cells during
homeostatic renewal. In this scenario, EZH2 ablation would
precipitate an underlying natural process that would provide sec-
ondary GATA4-positive progenitors once the pool of physiological
SHH-positive progenitors is exhausted. Whether these cells are
required to maintain homeostasis of the aging adrenal remains to
be determined.
We have previously shown accumulation of spindle-shaped
subcapsular cells in mice with constitutive WNT pathway activa-
tion (ΔCat) (25), overexpression of IGF2 (AdIGF2), and a com-
bination of both (ΔCat;AdIgf2) (38). Analysis of tissue sections
shows up-regulation of Gli1, Gata4, and Wt1 in the subcapsular
area in all three models (SI Appendix, Fig. S9), consistent with our
observations in Ezh2 KO adrenals. Although these mice do not
harbor the mTmG reporter, precluding lineage analysis, this
suggests that accumulation of progenitor-like cells in these models
may result from a similar dedifferentiation mechanism. However,
this is mitigated by the observation that they accumulate in the
context of Shh up-regulation in ΔCat mice, which is in contrast
with Ezh2 KO (Fig. 4) and AdIgf2 adrenals (SI Appendix, Fig. S9).
Thorough lineage tracing experiments will be required to evaluate
the possibility of a unifying mechanism explaining the appearance
of these progenitor-like cells in the adrenal cortex.
Although both WT1 and GATA4 are required for early de-
velopment of the adrenal primordium, their expression is extin-
guished in adrenal steroidogenic cells after emergence of the
adrenal anlagen from the AGP at E10.5 (18). On the basis of our
ChIP data, EZH2 could be considered a good candidate re-
pressor in this context. However, Ezh2 ablation did not result in
overexpression of GATA4 and WT1 before E14.5 and E18.5,
respectively. This suggests that other repressive factors may be
involved in this process. Alternatively, even though we did not
detect overexpression of EZH1 in adult Ezh2 KO adrenals (data
not shown), it may be compensating for loss of EZH2 during
early embryonic development. Such a compensatory mechanism
has been demonstrated in mouse hepatocytes (39) or in mouse
cardiomyocytes (40), and may explain the lack of gonadal phe-
notype in our model (SI Appendix, Fig. S5).
EZH2 is generally considered to be a factor that maintains
stem/progenitor cells in an undifferentiated state, and its in-
activation results in aberrant engagement and differentiation.
Indeed, EZH2 ablation in human embryonic stem cells results in
aberrant activation of multiple differentiation programs (41).
This function is maintained in adult hematopoietic stem cells
(42), myoblasts (43, 44), and neural stem cells (45, 46), and
forced overexpression of EZH2 after differentiation is capable of
inducing dedifferentiation of astrocytes toward neural stem cells
(47). In marked contrast, our data show that EZH2 is mostly
expressed in differentiated adrenal cortex cells. Its ablation in
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these cells results in their dedifferentiation toward a progenitor-
like state, and is also associated with a decreased capacity to
respond to differentiation signals such as ACTH/cAMP/PKA
signaling. This emphasizes the multiple and sometimes contra-
dictory functions of EZH2, and raises the question of the role of
EZH1 or other epigenetic factors in maintaining the undiffer-
entiated status of adrenal progenitor cells.
Altogether, our data show a novel role of the histone meth-
yltransferase EZH2 as a master regulator of PKA signaling in
adrenal cortex homeostasis and differentiation.
Materials and Methods
Ezh2 KO mice were obtained by mating Ezh2 Fl/Fl mice from the MMRRC
repository [strain 015499_UNC, generated by Tarakhovsky and coworkers
(13)] with Sf1:Cre mice [generated by Bingham et al. (12)]. Data on adult
mice in Figs. 1–5 were generated on tissues from 2-mo-old female mice. Data
on adult mice in SI Appendix, Figs. S7 and S8 were generated from 2-mo-old
male mice. Mouse experiments have been approved by Comité d’éthique
pour l’Expérimentation Animale Auvergne. A detailed description of mate-
rials and methods is provided in SI Appendix, Materials and Methods.
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